Form D — Medicenna Therapeutics Corp.
0001807983-26-000003 · filed 2026-07-06
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $2,343,400
- Total sold
- $253,458
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Medicenna Therapeutics Corp.
- CIK
- 1807983
- Entity
- Corporation
- Jurisdiction
- CANADA (FEDERAL LEVEL)
- Year incorporated
- —
- Address
- 2 BLOOR STREET W
TORONTO, A6 M4W 3E2 - Phone
- 604-671-6673
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Fahar Merchant · Executive OfficerToronto, A6 Find on LinkedIn ↗
-
David Hyman · Executive OfficerToronto, A6 Find on LinkedIn ↗
-
Nageatte Ibrahim · Executive OfficerToronto, A6 Find on LinkedIn ↗
-
Rosemina Merchant · Executive OfficerToronto, A6 Find on LinkedIn ↗
-
Albert G. Beraldo · DirectorToronto, A6 Find on LinkedIn ↗
-
John Geltosky · DirectorToronto, A6 Find on LinkedIn ↗
-
Karim Lalji · DirectorToronto, A6 Find on LinkedIn ↗
-
Richard Sutin · DirectorToronto, A6 Find on LinkedIn ↗
-
Angelos Georgakis · DirectorToronto, A6 Find on LinkedIn ↗
View original on SEC EDGAR.